| dc.contributor.author | Dawson Angela | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2012-10-12T03:34:22Z | |
| dc.date.available | 2012-10-12T03:34:22Z | |
| dc.date.issued | 2012 | en_US |
| dc.identifier | 2010005808 | en_US |
| dc.identifier.citation | Dawson Angela 2012, 'The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature', Thomson Reuters, vol. 23, no. 2, pp. 94-102. | en_US |
| dc.identifier.issn | 0955-3959 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/18558 | |
| dc.description.abstract | Injecting drug users (IDUs) are at increased risk of health problems ranging from injecting-related injuries to blood borne viral infections. Access to primary healthcare (PHC) is often limited for this marginalised group. Many seek care at emergency departments and some require hospital admission due to late presentation. The costs to both the individual and the health system are such that policymakers in some settings have implemented IDU-targeted PHC centres, with a number of models employed. However, there is insufficient evidence on the effectiveness of these centres to inform health service planning. A systematic review examining such interventions is not possible due to the heterogeneous nature of study designs. Nevertheless, an integrative literature review of IDU-targeted PHC may provide useful insights into the range of operational models and strategies to enhance the accessibility and acceptability of these services to the target population. | en_US |
| dc.language | en_US | |
| dc.publisher | Thomson Reuters | en_US |
| dc.relation.isbasedon | 10.1016/j.drugpo.2011.08.005 | en_US |
| dc.title | The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature | en_US |
| dc.parent | International Journal of Drug Policy | en_US |
| dc.journal.volume | 23 | en_US |
| dc.journal.number | 2 | en_US |
| dc.publocation | London | en_US |
| dc.identifier.startpage | 94 | en_US |
| dc.identifier.endpage | 102 | en_US |
| dc.cauo.name | FOH.Faculty of Health | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 119900 | en_US |
| dc.personcode | 111637 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Other Medical and Health Sciences | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | en_US | |
| dc.description.keywords | Primary healthcare; Injecting drug users; Harm reduction; Narrative synthesis | en_US |
| dc.staffid | en_US |